Salbutamol

Salbutamol (Albuterol) 10mg by Dragon Pharma

Salbutamol (known as Albuterol in the US) is Dragon Pharma's formulation of oral Salbutamol at 10mg per tablet — a short-acting beta-2 adrenergic agonist originally developed as a bronchodilator, used in performance contexts for its thermogenic, lipolytic and anti-catabolic properties. At 10mg per tablet, this is a high-dose oral formulation — significantly above standard asthma dosing — designed for users seeking the systemic beta-2 effects rather than bronchodilation alone.

Also searched as: Albuterol 10mg, Salbutamol tablets oral, Albuterol oral fat loss, Salbutamol Dragon Pharma.

Salbutamol vs Clenbuterol — The Critical Pharmacological Differences

Salbutamol and Clenbuterol are both beta-2 agonists and are frequently compared, but their pharmacological profiles differ in several important ways that affect how they are used:

Why Salbutamol's Short Half-Life Changes the Receptor Dynamic

This is the most important pharmacological distinction and the least explained in competitor content:

• Clenbuterol's ~35-40 hour half-life means it is present at active concentrations 24 hours a day — beta-2 receptors are continuously occupied, driving the well-documented 50% downregulation within 2 weeks that necessitates the 2-week on/off cycling protocol
• Salbutamol's ~4-6 hour half-life means there are natural low-concentration windows between doses — beta-2 receptors are not continuously saturated and have time for partial recovery
• The practical consequence: Salbutamol users often run it continuously without strict 2-week cycling, instead relying on the natural trough periods between doses to prevent the degree of receptor downregulation Clenbuterol produces
• This does not mean receptor downregulation is absent with Salbutamol — it occurs, but at a slower and more manageable rate that the short half-life partially accommodates

Oral vs Inhaled Salbutamol — An Important Distinction

Salbutamol is most commonly known as an inhaled medication (Ventolin inhaler) for asthma. Oral Salbutamol at 10mg represents a fundamentally different application:

• Inhaled Salbutamol reaches the airway at very low systemic concentrations — the goal is local bronchodilation with minimal systemic absorption. A standard inhaled dose is 100-200mcg, producing local airway effect with very little reaching systemic circulation
• Oral Salbutamol at 10mg enters the bloodstream systemically — producing the full range of beta-2 effects throughout the body including adipose tissue (lipolysis), skeletal muscle (anti-catabolism), and the cardiovascular system
• The dose difference is approximately 50-100× — 10mg oral vs 0.1-0.2mg inhaled — reflecting the different goals and pharmacokinetics of each route

Effects and Benefits

• Thermogenic effect — increased basal metabolic rate via beta-2 receptor activation in adipose tissue (less potent than Clenbuterol per dose)
• Lipolytic activity — hormone-sensitive lipase (HSL) activation driving fatty acid release from adipocytes
• Anti-catabolic effect in skeletal muscle — beta-2 receptor activation reduces muscle protein breakdown via mTOR pathway stimulation, same mechanism as Clenbuterol
• Bronchodilation — vasodilation of airways, improving oxygen delivery during training
• Higher beta-2 selectivity than Clenbuterol — potentially milder cardiovascular side effects at equivalent anabolic doses
• No suppression of natural testosterone — does not require Post Cycle Therapy

Dosage and Administration

At 10mg per tablet, the Dragon Pharma formulation delivers a high per-tablet dose — the 10mg tablet is typically split for the lower doses or taken whole for higher-dose protocols. Due to the ~4-6 hour half-life, 3-4 daily doses maintain more stable blood levels than once-daily dosing would provide. Morning and pre-workout dosing is preferred for the later doses — the sympathomimetic stimulation affects sleep if taken in the evening.